24.08.2013 Views

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

2009 Vienna - European Society of Human Genetics

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Prenatal and perinatal genetics<br />

developing RDS in neonates from Bashkortostan Republic, Russia.<br />

The whole peripheral blood <strong>of</strong> 159 patients with respiratory disease<br />

and umbilical cord blood <strong>of</strong> 299 healthy term neonates was used for<br />

the isolation <strong>of</strong> genomic DNA. The patient group consisted <strong>of</strong> 3 subgroups<br />

(63 neonates with pneumonia, 40 babies with RDS and 53 infectious<br />

complicated RDS) The genomic DNA served for PCR in the<br />

genotype analysis.<br />

The results demonstrated that SFTPD (Met11Thr, Ala160Thr) gene<br />

genotypes frequency distribution patterns not significantly differ<br />

between patients with RDS and healthy neonates (χ 2 =2.68, df=2,<br />

p=0.262; χ 2 =1.31, df=2, p=0.518).<br />

The SFTPD Thr/Thr genotype is protective against the development<br />

complication in RDS (7.5% vs. 32.5%; χ 2 =7.9, p=0.006; OR=0.17,<br />

95%CI 0.04-0.64). Whereas, children with RDS who has the Met/Thr<br />

genotype were susceptible to infectious complication (73.6% vs. 50%;<br />

χ 2 =4.5, p=0.003; OR=2.79, 95%CI 1.07-7.32).<br />

We suppose that the Met11Thr polymorphism <strong>of</strong> SFTPD gene may play<br />

a significant role in the development <strong>of</strong> complicated RDS in neonates.<br />

P05.32<br />

Prenatal diagnosis <strong>of</strong> a fetus with ring chromosome 21<br />

characterized by molecular cytogenetic methods<br />

I. D. Papoulidis 1 , E. Siomou 1 , E. Manolakos 2 , T. Liehr 3 , A. Vetro 4 , A. P. Athanasiadis<br />

5 , O. Zuffardi 4 , M. B. Petersen 1 ;<br />

1 Eurogenetica S.A., Thessaloniki, Greece, 2 Bioiatriki, Athens, Greece, 3 Friedrich-Schiller-University,<br />

Jena, Germany, 4 Universita di Pavia, Pavia, Italy, 5 Aristotle<br />

University, Thessaloniki, Greece.<br />

Ring chromosome 21 is a rare structural chromosomal abnormality<br />

resulting, most <strong>of</strong> the times, from breakage in both arms <strong>of</strong> the chromosome<br />

and subsequent fusion <strong>of</strong> the two ends. There is a wide spectrum<br />

<strong>of</strong> phenotypes in ring 21 carriers that seems to be associated<br />

with different breakpoints <strong>of</strong> 21p and q arms, but also with somatic loss<br />

<strong>of</strong> the ring. Here we report a case <strong>of</strong> a fetus that was diagnosed with<br />

mos46,XY,r(21)(p11.2q22)[34]/45,XY,-21[4]/46,XY[14] karyotype. Ultrasound<br />

examination at 21 weeks’ gestation showed no abnormalities<br />

and amniocentesis opted due to advanced maternal age. Cytogenetic<br />

analysis was performed in the parents and showed the presence <strong>of</strong> the<br />

ring chromosome in 1 out <strong>of</strong> 100 metaphases in the father, indicating<br />

a possible familial transmission. Analysis by Fluorescent In Situ Hybridization<br />

(FISH) and comparative genomic hybridization (aCGH) with<br />

resolution <strong>of</strong> 144 kb showed no deletion or duplication. After genetic<br />

counseling, the parents decided to continue the pregnancy and postnatal<br />

examination just after birth found no congenital abnormalities.<br />

P05.33<br />

Robinow syndrome revealed during pregnancy on limb<br />

anomalies<br />

D. Meyran 1,2 , F. Escande 3 , A. Dieux-coeslier 1,2 , C. Chafiotte 4 , D. Thomas 1,5 , P.<br />

Dufour 1,5 , J. Andrieux 1,6 , S. Manouvrier-Hanu 1,2 , M. Holder 1,2 ;<br />

1 Jeanne de Flandre, Lille, France, 2 Clinical <strong>Genetics</strong>, Lille, France, 3 Centre de<br />

Biologie Pathologie, Lille, France, 4 Radiologie, Lyon, France, 5 Maternity, Lille,<br />

France, 6 Genomic platform, Lille, France.<br />

Robinow syndrome is a rare disease characterised by the association<br />

<strong>of</strong> mesomelic limb shortening, facial and genital anomalies. It can<br />

be inherited in an autosomal dominant or recessive mode. Recessive<br />

forms are severe and the result <strong>of</strong> ROR2 mutations, whereas the aetiology<br />

<strong>of</strong> dominant forms remains unknown. We report a further case <strong>of</strong><br />

Robinow syndrome diagnosed at birth, with interesting prenatal findings.<br />

Parents were healthy and not consanguineous. The mother was 39year-old.<br />

The first trimester ultrasound showed an increased nuchal<br />

translucency (2.7 mm). Karyotype on amniotic fluid was normal (46,<br />

XX). The second trimester ultrasound revealed short ulna and radii (5 th<br />

centile). A spiral CT scan revealed delayed ossification and a mesoaxial<br />

polydactyly on both feet. A chondrodysplasia was suggested and<br />

pregnancy was followed since no definite diagnosis could be realised.<br />

The baby girl was born at 39WG with a normal weight and head circumference<br />

but a decreased length (47 cm, 25 th centile). Characteristic<br />

facial features were noted comprising hypertelorism, short upturned<br />

nose and gum hypertrophy. Mesomelic limb shortening and bilateral<br />

polydactyly <strong>of</strong> the feet were observed. Skeletal X-rays confirmed the<br />

bilateral mesoaxial polydactyly, revealed bifid terminal phalanges <strong>of</strong><br />

both thumbs and did not show any vertebral anomalies. Cardiac, trans-<br />

fontanellar, renal ultrasonography and eye examination were normal.<br />

Robinow syndrome was then diagnosed.<br />

ROR2 molecular analysis was normal. Array-CGH is pending.<br />

Even though Robinow syndrome has, to our knowledge, never been<br />

diagnosed during pregnancy on ultrasound findings, it should be suggested<br />

on the association <strong>of</strong> short long bones and mesoaxial polydactyly.<br />

P05.34<br />

split hand-split foot malformation due to 10q24 duplication<br />

identified during pregnancy on array-CGH<br />

M. Holder-Espinasse 1 , A. Valat 2 , A. Mézel 3 , P. Bourgeot 4 , S. Manouvrier-<br />

Hanu 1 , J. Andrieux 5 ;<br />

1 Service de Génétique Clinique, Hôpital Jeanne de Flandre, Lille, France, 2 Service<br />

de Gynécologie-Obstétrique, Centre Hospitalier, Lens, France, 3 Service de<br />

Chirurgie orthopédique, Hôpital Jeanne de Flandre, Lille, France, 4 Service de<br />

Gynécologie Obstétrique, Hôpital Jeanne de Flandre, Lille, France, 5 Laboratoire<br />

de Génétique médicale, Hôpital Jeanne de Flandre, Lille, France.<br />

Ectrodactyly or split hand-split foot malformation (SHFM) is a rare<br />

condition that occurs in 1 in 8500-25000 newborns and accounts for<br />

around 15 % <strong>of</strong> all limb reduction defects. SHFM is clinically heterogeneous<br />

and can be either isolated, associated with other malformations<br />

or part <strong>of</strong> syndromic entities. This condition is usually inherited<br />

in an autosomal dominant manner and several loci have been identified.<br />

Among them, SHFM3 has been located on 10q24 and the naturally<br />

occurring Dactylaplasia mouse is the animal model for SHFM3 in<br />

humans. Recently, 0.5 Mb tandem genomic duplications at chromosome<br />

10q24 involving at least the DACTYLIN gene have been found<br />

in SHFM3 patients. No point mutations in any <strong>of</strong> the genes residing<br />

within the duplicated region have been reported so far, and it is still not<br />

clear how this rearrangement leads to the SHFM3 phenotype. Indeed,<br />

complex alterations <strong>of</strong> gene regulation mechanisms that would impair<br />

limb morphogenesis are likely.<br />

We report on the third pregnancy <strong>of</strong> healthy non consanguineous<br />

parents presenting normal hands and feet. At 23WG, the routine ultrasound<br />

scan identified a split hand-split foot malformation. Chromosomes<br />

on amniotic fluid were normal 46XX and array-CGH shown a de<br />

novo 400 kb 10q24.31q24.32 duplication, comprising 5 genes including<br />

DACTYLIN. Reassuring genetic counselling was performed since<br />

these forms <strong>of</strong> SHFM are isolated and non-syndromic. At birth, limb<br />

anomalies were confirmed and corrective surgery performed.<br />

To our knowledge, this is the first prenatal report <strong>of</strong> 10q24 duplication<br />

in SHFM.<br />

P05.35<br />

Antenatal population carrier screening for spinal muscular<br />

atrophy<br />

S. Y. Lin, Y. N. Su, C. N. Lee;<br />

National Taiwan University Hospital, Taipei, Taiwan.<br />

Background<br />

SMA is one <strong>of</strong> the most common autosomal recessive diseases with<br />

a carrier frequency <strong>of</strong> approximately to 1 in 50. Due to the incidence<br />

and severity <strong>of</strong> SMA and the availability <strong>of</strong> a carrier-screening test, we<br />

embarked on a stepwise prenatal SMA carrier screening program in<br />

Taiwan.<br />

Methods<br />

A total <strong>of</strong> 70,048 pregnant women participated in this carrier-screening<br />

program from 2005 to 2008. In the first phase, we used DHPLC as the<br />

single tool for genetic testing. In the second phase, we combined the<br />

DHPLC and MLPA for the test. If a woman was found to be a SMA carrier,<br />

her husband was asked to take the genetic test. If they both were<br />

SMA carriers, prenatal genetic diagnosis was suggested.<br />

Results<br />

A total <strong>of</strong> 40,756 pregnant women received the single-tool screening;<br />

1,726 (4.2%) were discovered to be at high risk <strong>of</strong> being SMA carriers.<br />

Of these 1,726 couples, 62 husbands were also at high risk <strong>of</strong> being<br />

SMA carriers. Five fetuses from these couples were affected SMA<br />

cases. A total <strong>of</strong> 29,292 pregnant women received the combined tests;<br />

the results showed 603 (2.1%) were SMA carriers; twenty husbands<br />

were SMA carriers. Six fetuses from this group were affected SMA<br />

cases. This screening program cost $401,202 US dollars to avoid a<br />

SMA affected child being born.<br />

Conclusion

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!